Careers Header Bg
Regask Sprim Pro Infant Formula 2
REGASK JOINS

Infant Formula & Nutrition Webinar Series

Watch Webinar Watch Webinar

Meet the team

Alice Gravereaux, Senior Regulatory Affairs Manager at RegASK, spoke at the SPRIM PRO Infant Formula & Nutrition Webinar on July 31, 2025. She shared real-world case studies on:

🔹 Compliant Gut Health Claims for entering the US market
🔹 Hybrid Clinical Trials using digital diaries and e-consents
🔹 Global Risk Monitoring with the RegASK platform

The session highlighted how RegASK enables compliant, scalable innovation in infant nutrition.

Sprim Pro If Webinar

Alice Gravereaux

Senior Regulatory Affairs Manager

Bg Flip Card 1
Watch Webinar Watch Webinar

SPRIM PRO Infant Formula & Nutrition Webinar Series

Maximizing Data Quality and Completeness for Caregiver Reporting of Infant GI Symptoms and Study Formula Intake in a Growth Monitoring Study

Delve into SPRIM PRO’s innovative approaches to optimizing caregiver-reported data in infant formula clinical trials. This webinar emphasizes cutting-edge strategies to improve the reliability and depth of infant gastrointestinal (GI) symptom reporting and formula intake monitoring.

What You’ll Learn

  • Technology‑Enabled Data Capture
    Discover the design of caregiver e‑diaries and next-gen ePRO systems for accurately logging GI symptoms, formula intake, tolerability, and anthropometrics
  • Digital & Multimedia Training
    Learn how multimedia training programs help caregivers report more objectively, reducing variability and improving data accuracy
  • Telehealth‑Supported Remote Monitoring
    Explore how telehealth and pediatric‑nurse oversight enable caregivers to collect growth data at home through standardized remote protocols

Why Attend?

  • Ensure Data Integrity
    Achieve higher consistency and completeness in caregiver data via structured digital frameworks and built-in checks.
  • Minimize Burden & Boost Engagement
    Leverage decentralized, hybrid methodologies to ease participation and improve compliance—without needing frequent clinic visits
  • Learn from Proven FDA‑Approved Designs
    Gain insights from SPRIM PRO’s more than 20 years’ experience and multiple fully decentralized FDA-approved infant nutrition trials

Webinar Details

🗓️ Date: July 31, 2025
🕐 Time: 10:00 AM – 11:00 AM SGT
🌐 Location: Virtual (Free registration required)

This session is proudly supported by RegASK, a leader in AI-driven regulatory intelligence and workflow orchestration. We help life sciences and nutrition companies monitor evolving regulations, ensure global compliance, and streamline regulatory submissions with confidence and speed.

Don’t miss this opportunity to strengthen your knowledge in pediatric clinical research and explore cutting-edge strategies for improving data quality in infant formula trials—while learning how AI solutions like RegASK are transforming regulatory operations.

Watch Webinar Watch Webinar

Our solution

RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.

Resources

Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more